By Michael Gwarisa For more than a century, the Bacillus Calmette-Guérin (BCG) vaccine has been the world’s main vaccine against tuberculosis, protecting millions of children from severe forms of the disease. But the vaccine’s limitations have become increasingly difficult to ignore. While BCG remains an important tool for protecting infants and young children, it has